Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
December 19, 2019
Disposition of [<sup>14</sup>C]LY2606368 following intravenous administration in patients with advanced and/or metastatic solid tumours
Enaksha R Wickremsinhe, Scott M Hynes, Christopher D Payne, et al.
Clinical Pharmacology in Drug Development
|
September 18, 2020
Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study
Xia Zhao, Xiao Yan Sheng, Christopher D Payne, et al.
Thrombosis and Haemostasis
|
June 15, 2011
Absence of "rebound" platelet hyperreactivity following cessation of prasugrel
Joseph A Jakubowski, Ying G Li, Christopher D Payne, et al.
Platelets
|
September 1, 2007
Clopidogrel poor responders: an objective definition based on Bayesian classification
Govinda J Weerakkody, John T Brandt, Christopher D Payne, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 19, 2007
Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis
Govinda J Weerakkody, Joseph A Jakubowski, John T Brandt, et al.
Plos One
|
November 27, 2013
Iron limitation modulates ocean acidification effects on southern ocean phytoplankton communities
Clara J M Hoppe, Christel S Hassler, Christopher D Payne, et al.
Advances in Therapy
|
April 22, 2022
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
Sanjay Chabra, B J Gill, Gaia Gallo, et al.
Advances in Therapy
|
September 3, 2025
Pharmacokinetic Bridging Between an Autoinjector and a Prefilled Syringe Following Subcutaneous Administration of Mirikizumab in Healthy Participants
Xin Zhang, Yuki Otani, Christopher D Payne, et al.
British Journal of Clinical Pharmacology
|
July 22, 2014
Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects
Christopher D Payne, Mark A Deeg, Melanie Chan, et al.
Journal of Cardiovascular Pharmacology
|
April 14, 2010
A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis
Joseph A Jakubowski, Ying G Li, David S Small, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
December 19, 2019
Disposition of [<sup>14</sup>C]LY2606368 following intravenous administration in patients with advanced and/or metastatic solid tumours
Enaksha R Wickremsinhe, Scott M Hynes, Christopher D Payne, et al.
Clinical Pharmacology in Drug Development
|
September 18, 2020
Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study
Xia Zhao, Xiao Yan Sheng, Christopher D Payne, et al.
Thrombosis and Haemostasis
|
June 15, 2011
Absence of "rebound" platelet hyperreactivity following cessation of prasugrel
Joseph A Jakubowski, Ying G Li, Christopher D Payne, et al.
Platelets
|
September 1, 2007
Clopidogrel poor responders: an objective definition based on Bayesian classification
Govinda J Weerakkody, John T Brandt, Christopher D Payne, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 19, 2007
Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis
Govinda J Weerakkody, Joseph A Jakubowski, John T Brandt, et al.
Plos One
|
November 27, 2013
Iron limitation modulates ocean acidification effects on southern ocean phytoplankton communities
Clara J M Hoppe, Christel S Hassler, Christopher D Payne, et al.
Advances in Therapy
|
April 22, 2022
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
Sanjay Chabra, B J Gill, Gaia Gallo, et al.
Advances in Therapy
|
September 3, 2025
Pharmacokinetic Bridging Between an Autoinjector and a Prefilled Syringe Following Subcutaneous Administration of Mirikizumab in Healthy Participants
Xin Zhang, Yuki Otani, Christopher D Payne, et al.
British Journal of Clinical Pharmacology
|
July 22, 2014
Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects
Christopher D Payne, Mark A Deeg, Melanie Chan, et al.
Journal of Cardiovascular Pharmacology
|
April 14, 2010
A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis
Joseph A Jakubowski, Ying G Li, David S Small, et al.
Page
of 4